β2-Adrenoceptor agonists as novel, safe and potentially effective therapies for Amyotrophic lateral sclerosis (ALS)
about
Neuromuscular junction degeneration in muscle wasting.Risk of sepsis in patients with amyotrophic lateral sclerosis: a population-based retrospective cohort study in Taiwan.Beta-agonist stimulation ameliorates the phenotype of spinal and bulbar muscular atrophy mice and patient-derived myotubes.Could Sirtuin Activities Modify ALS Onset and Progression?Synaptic Homeostasis and Its Immunological Disturbance in Neuromuscular Junction Disorders.Chronic electromyograms in treadmill running SOD1 mice reveal early changes in muscle activation.
P2860
β2-Adrenoceptor agonists as novel, safe and potentially effective therapies for Amyotrophic lateral sclerosis (ALS)
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
β2-Adrenoceptor agonists as no ...... rophic lateral sclerosis (ALS)
@ast
β2-Adrenoceptor agonists as no ...... rophic lateral sclerosis (ALS)
@en
β2-Adrenoceptor agonists as no ...... rophic lateral sclerosis (ALS)
@nl
type
label
β2-Adrenoceptor agonists as no ...... rophic lateral sclerosis (ALS)
@ast
β2-Adrenoceptor agonists as no ...... rophic lateral sclerosis (ALS)
@en
β2-Adrenoceptor agonists as no ...... rophic lateral sclerosis (ALS)
@nl
prefLabel
β2-Adrenoceptor agonists as no ...... rophic lateral sclerosis (ALS)
@ast
β2-Adrenoceptor agonists as no ...... rophic lateral sclerosis (ALS)
@en
β2-Adrenoceptor agonists as no ...... rophic lateral sclerosis (ALS)
@nl
P2093
P1476
β2-Adrenoceptor agonists as no ...... rophic lateral sclerosis (ALS)
@en
P2093
Alexandre Bétourné
Anthony Basile
Bethany L Peterson
Jonathan Glass
Nicholas M Boulis
Raymond T Bartus
P356
10.1016/J.NBD.2015.10.006
P407
P577
2016-01-01T00:00:00Z